Hepatitis B Vaccine Market Set for 5.72% Growth to USD 12.95 billion by 2034
From USD 7.85 billion in 2025 to USD 12.95 billion in 2034, a 5.72% compound annual rate.
Market findings and research announcements from the CDI research team. Showing 61–72 of 109.
From USD 7.85 billion in 2025 to USD 12.95 billion in 2034, a 5.72% compound annual rate.
From USD 405 billion in 2025 to USD 1026.7 billion in 2034, a 10.8% compound annual rate.
Market reaches USD 9.15 billion by 2034, up from USD 3.35 billion in 2025, at a 11.83% CAGR.
Market reaches USD 25.65 billion by 2034, up from USD 13.5 billion in 2025, at a 7.25% CAGR.
Market reaches USD 51.81 billion by 2034, up from USD 32 billion in 2025, at a 5.5% CAGR.
Market reaches USD 99.6 billion by 2034, up from USD 65.5 billion in 2025, at a 4.81% CAGR.
From USD 9.85 billion in 2025 to USD 20.21 billion in 2034, a 8.31% compound annual rate.
From USD 70.5 billion in 2025 to USD 142 billion in 2034, a 8.13% compound annual rate.
From USD 1.08 billion in 2025 to USD 3.302 billion in 2034, a 13.13% compound annual rate.
Market reaches USD 16.6 billion by 2034, up from USD 6.05 billion in 2025, at a 11.7% CAGR.
From USD 2.05 billion in 2025 to USD 5.24 billion in 2034, a 11.02% compound annual rate.
From USD 5.4 billion in 2025 to USD 16.05 billion in 2034, a 12.29% compound annual rate.
For comment on a published finding, or to request the full study behind a release, contact the research team.